Topics

Nephros Announces Presentations at Five Upcoming Investor Conferences

20:00 EDT 2 Sep 2019 | Globe Newswire

SOUTH ORANGE, NJ, Sept. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced presentations at five upcoming investor conferences.

Daron Evans, President and Chief Executive Officer, and Andy Astor, Chief Operating and Financial Officer, will provide overviews of Nephros’ business during the conferences and will be available for one-on-one meetings with registered participants. Company information, including the most recent corporate presentation, is available on the Nephros website: https://www.nephros.com/investor-relations/

LD Micro San Francisco Summit
Date: Tuesday, September 3
Time: 8:40am Pacific Time
Location: JW Marriott, San Francisco
Speaker: Daron Evans
For more information: https://www.ldmicro.com

RHK Capital 2019 Disruptive Growth Conference
Date: Wednesday, September 4
Time: 2:40pm Eastern Time
Location: Reed Smith, New York, NY
Speaker: Andy Astor
For more information and webcast: http://disruptnyc.com

Fall Investor Summit
Date: Monday, September 16
Time: 9:00am Eastern Time
Location: The Essex House, New York, NY
Speaker: Andy Astor
For more information: https://microcapconf.com

MicroCap Leadership Summit
Date: Friday, September 27, 2019
Time: All day
Location: Westin Chicago Northwest Hotel, Itasca, Illinois
Speaker: Andy Astor

For more information: https://microcapclub.com/summit/

LD Micro New York City Summit
Date: Monday, October 7, 2019
Time: 9:00am Eastern Time
Location: Lowenstein Sandler, 1251 6th Ave., New York, NY
Speaker: Andy Astor
For more information: https://www.ldmicro.com/events

About Nephros, Inc.

Nephros is a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets. Nephros ultrafilters are used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters are used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients.

Nephros filters, including AETHER™ brand filters, improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets.

For more information about Nephros, please visit our website at www.nephros.com.

Investor Relations Contact:

Kirin Smith, President
PCG Advisory, Inc.
(646) 863-6519
ksmith@pcgadvisory.com

Primary Logo

NEXT ARTICLE

More From BioPortfolio on "Nephros Announces Presentations at Five Upcoming Investor Conferences"

Quick Search

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Dialysis
In medicine, dialysis is a process for removing waste and excess water from the blood, and is primarily used to provide an artificial replacement for lost kidney function in people with renal failure. Dialysis may be used for those with an acute disturba...